Apex Biotechnology Corp
TWSE:1733

Watchlist Manager
Apex Biotechnology Corp Logo
Apex Biotechnology Corp
TWSE:1733
Watchlist
Price: 29.75 TWD 0.51% Market Closed
Market Cap: 3B TWD

Profitability Summary

Apex Biotechnology Corp's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Apex Biotechnology Corp

Revenue
2B TWD
Cost of Revenue
-1.4B TWD
Gross Profit
557.4m TWD
Operating Expenses
-401.9m TWD
Operating Income
155.5m TWD
Other Expenses
-4.7m TWD
Net Income
150.8m TWD

Margins Comparison
Apex Biotechnology Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
TW
Apex Biotechnology Corp
TWSE:1733
3B TWD
28%
8%
8%
US
Abbott Laboratories
NYSE:ABT
214.8B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
194.1B USD
66%
29%
29%
US
Stryker Corp
NYSE:SYK
138.6B USD
65%
22%
12%
US
Boston Scientific Corp
NYSE:BSX
133.4B USD
69%
19%
14%
IE
Medtronic PLC
NYSE:MDT
126.9B USD
66%
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
52.1B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD
46%
16%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD
62%
31%
25%
US
Edwards Lifesciences Corp
NYSE:EW
49.1B USD
78%
28%
23%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.6B USD
41%
14%
11%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Apex Biotechnology Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
TW
Apex Biotechnology Corp
TWSE:1733
3B TWD
8%
6%
8%
7%
US
Abbott Laboratories
NYSE:ABT
214.8B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
194.1B USD
17%
15%
17%
22%
US
Stryker Corp
NYSE:SYK
138.6B USD
14%
6%
14%
12%
US
Boston Scientific Corp
NYSE:BSX
133.4B USD
13%
7%
11%
9%
IE
Medtronic PLC
NYSE:MDT
126.9B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
52.1B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD
7%
3%
7%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD
65%
31%
58%
35%
US
Edwards Lifesciences Corp
NYSE:EW
49.1B USD
14%
10%
14%
16%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.6B USD
24%
6%
11%
8%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less